Acceptability and Tolerance of Hysteroscopy and Hysterosonography in Consultation
NCT03121560 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110
Last updated 2020-08-07
Summary
Menorrhagia is frequent and occur in 11 to 13 % of the general population. It accounts for 20% of the gynecological consultations and tends to increase with age. It can be the first symptom of a mild uterine disease or cancer (cervical or endometrial), especially if the patient is older. The most common causes are polyps, adenomyosis, fibroids, hyperplasia and cancer.
Menorrhagia needs to be investigated -especially after menopause, when the prevalence of endometrial cancer is higher (10-15%). For premenopausal metrorrhagia, the assessment will be made if a pathology is suspected or if there is no response to the medical treatment within 3 to 6 months.
The medical check-up consists in the first instance in a questionnaire, a clinical examination and an endovaginal ultrasound examination. If the endometrium is thickened, a focal pathology is suspected, or if the bleeding persists despite a normal endovaginal ultrasound result, further examinations including a possible biopsy are required.
While hysteroscopy is widely accepted as a standard examination for uterine cavity exploration, a meta-analysis showed that the diagnostic performance of hysterosonography was equivalent. Both are carried out on an outpatient basis during a gynecological consultation and require no special preparation. Several studies seem to show that hysterosonography is less painful, causes less discomfort and is therefore more accepted by patients than hysteroscopy. This is why many practitioners continue to prefer it to hysteroscopy and associate it with the Pipelle of Cornier for the assessment of postmenopausal metrorrhagia.
However, if endometrial cancer is confirmed, the histological type detected within the biopsy is the main predictor of the severity of the disease and the treatment to be given. It is therefore essential to have an accurate biopsy sampling prior to therapeutic management. It is not the case with blind biopsies (without visual control). Indeed, some studies showed that the concordance between the optical aspect of the endometrium under hysteroscopy and the histological result was close to 90%, validating the hypothesis of an improved sensitivity through visual control.
The American College of Obstetricians and Gynecologists (ACOG) currently recommends an endovaginal ultrasound assessment followed by an endometrial biopsy in the event of a thickened endometrium or when a pathology is suspected. A biopsy can even be taken during the consultation, at the onset of the complaints. The last recommendations of December 2010 leave the choice to clinicians regarding the histological diagnostic modalities (a blind biopsy with the Pipelle of Cornier or a targeted biopsy under hysteroscopy), although the biopsies under hysteroscopy are recommended since 2015. However, despite its poor sensitivity, the most widely used technique in the world is the blind biopsy by aspiration performed after vaginal ultrasound or hysterosonography because it is an easy low cost method.
The development of hysteroscopes with a smaller diameter and the introduction of the vaginoscopy have considerably increased the tolerance of this examination. In addition, hysteroscopy allows a simultaneous therapeutic intervention for certain indications, which is comfortable and well accepted by the patients. Unfortunately, there are few studies comparing the tolerance of the two examinations performed according to the current recommendations of good practice of hysteroscopy. Only one comparative randomized study in 2008 showed that saline infusion sonography (SIS) was less painful than hysteroscopy with vaginoscopy. However, direct comparison was impossible since women only had one of the two examinations.
The Brugmann University Hospital set up a consultation called "one stop bleeding clinic" in which the two examinations are performed for each patient with abnormal bleedings, in order to increase diagnostic performance.
All included patients will thus undergo a saline infusion sonography (SIS) and a hysteroscopy (HSC). Each procedure will be evaluated on pain level (EVA scale) and tolerance by the patient.
Conditions
- Metrorrhagia
Interventions
- DEVICE
-
Hysteroscopy
Hysteroscopy allows a direct visualization of the interior of the uterine cavity in order to invalidate or confirm the presence of uterine pathologies.In the pre-menopausal period, it is preferable to perform a hysteroscopy at the beginning of the follicular phase (just after the menstruations, when the endometrium is atrophic). Use of a rigid hysteroscope comprising a 2.9 mm optics and a 4.3 mm sheath with a 5 - bit operator channel allowing the realization of a biopsy.
- DEVICE
-
Hysterosonography
Hysterosonography (SIS) is an endovaginal ultrasound performed along with an injection of saline in order to observe the uterine cavity and detect any endometrial pathology. A 3D image can be associated with it to define the topography of a lesion. It is ideally performed in the first part of the cycle. Use of the GE Voluson E8 Ultrasound System.
Sponsors & Collaborators
-
Brugmann University Hospital
lead OTHER
Principal Investigators
-
André Nazac, MD · CHU Brugmann
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-11-14
- Primary Completion
- 2019-07-25
- Completion
- 2019-07-25
Countries
- Belgium
Study Locations
More Related Trials
-
Evaluation of a Hysteroscopic Morcellator in Hysteroscopic Treatment of Submucosal Fibroids
NCT02406898 ·Status: UNKNOWN ·Phase: NA
-
Hysteroscopic Surgery in Treatment of Intrauterine Abnormalities
NCT03265301 ·Status: WITHDRAWN ·Phase: NA
-
Incidence of Malignant and Premalignant Endometrial Polyp in Asymptomatic and Symptomatic Postmenopausal Women
NCT01203176 ·Status: UNKNOWN ·Phase: NA
-
Long-term Outcomes After Laparoscopic Subtotal and Total Hysterectomy
NCT05421156 ·Status: NOT_YET_RECRUITING
-
Morcellator Versus Resectoscope in the Treatment of Uterine Polyps by Hysteroscopy
NCT02472197 ·Status: COMPLETED ·Phase: NA
-
Management of Symptomatic Uterine Fibroids in Pregnancy by Laparotomic Myomectomy: a Prospective Cohort Study
NCT06009562 ·Status: UNKNOWN
-
Ulipristal vs. GnRHa Prior to Laparoscopic Myomectomy
NCT02288130 ·Status: UNKNOWN ·Phase: PHASE4
-
Prevalence of Intrauterine Adhesions After Abdominal Myomectomy
NCT04030273 ·Status: UNKNOWN
-
Correlation Between Hysteroscopic Diagnosis of Endometrial Hyperplasia and Histopathological Examination
NCT03917147 ·Status: COMPLETED
-
Assessing the Benefit of Pipelle Biopsy in Patients With Postmenopausal Bleeding and an Atrophic-appearing Cavity
NCT05378152 ·Status: COMPLETED ·Phase: NA
-
Implementation of Hysteroscopy in Flanders and the Netherlands
NCT02853695 ·Status: COMPLETED
-
Hand Driven Versus Motor Driven Hysteroscopic Tissue Removal System for Polypectomy: Long-term Results
NCT05337605 ·Status: COMPLETED
-
Hysteroscopic Assessment of Fallopian Tubal Patency
NCT02005263 ·Status: COMPLETED ·Phase: NA
-
The Benefits and Limits of Laparoscopic Surgery for Uterine Fibroids
NCT00860002 ·Status: UNKNOWN
-
Uterine Rupture After Hysteroscopic Septum Resection
NCT04449640 ·Status: COMPLETED
-
Long-Term Outcome Following Laparoscopic Supracervical Hysterectomy Performed With and Without Excision of the Endocervix in a Reverse Cone Pattern
NCT00921778 ·Status: UNKNOWN ·Phase: NA
-
HOME Study: Hysteroscopic Office Myomectomy Evaluation
NCT01152112 ·Status: COMPLETED ·Phase: NA
-
Pregnancy Outcomes Following Myomectomy
NCT06474065 ·Status: COMPLETED
-
Hysteroscopic Cryomyolysis for the Treatment of Submucosal Leiomyomata
NCT00731341 ·Status: COMPLETED ·Phase: NA
-
Uterine Cavity Assessment and Endometrial Hormonal Receptors in Women With Peri and Post Menopausal Bleeding
NCT02385747 ·Status: COMPLETED ·Phase: NA
-
Hysterectomy by Transabdominal Laparoscopy or NOTES
NCT02631837 ·Status: COMPLETED ·Phase: NA
-
Is There a Place for Pre-operative Temporary Embolization of Uterine Fibroids
NCT03989661 ·Status: COMPLETED
-
Optimal Order of Concurrent Office Hysteroscopy and Endometrial Biopsy
NCT02472184 ·Status: COMPLETED ·Phase: NA
-
The Use of a Morcellator in Operative Hysteroscopy for Benign Intracavitary Lesions: a Feasibility Study
NCT05811286 ·Status: COMPLETED ·Phase: NA
-
The Incidence of Pelvic Hematoma Following Hysterectomy
NCT01498315 ·Status: COMPLETED